During atherogenesis, excess amounts of low-density lipoproteins (LDL) accumulate in the subendothelial space where they undergo oxidative modifications. Oxidized LDL (oxLDL) alter the fragile balance between survival and death of vascular smooth muscle cells (VSMC) thereby leading to plaque instability and finally to atherothrombotic events. As protein kinase C d (PKCd) is pro-apoptotic in many cell types, we investigated its potential role in the regulation of VSMC apoptosis induced by oxLDL. We found that human VSMC silenced for PKCd exhibited a protection towards oxLDL-induced apoptosis. OxLDL triggered the activation of PKCd as shown by its phosphorylation and nuclear translocation. PKCd activation was dependent on the reactive oxygen species generated by oxLDL. Moreover, we demonstrated that PKCd participates in oxLDL-induced endoplasmic reticulum (ER) stress-dependent apoptotic signaling mainly through the IRE1a/JNK pathway. Finally, the role of PKCd in the development of atherosclerosis was supported by immunohistological analyses showing the colocalization of activated PKCd with ER stress and lipid peroxidation markers in human atherosclerotic lesions. These findings highlight a role for PKCd as a key regulator of oxLDL-induced ER stress-mediated apoptosis in VSMC, which may contribute to atherosclerotic plaque instability and rupture.
During atherogenesis, excess amounts of low-density lipoproteins (LDL) accumulate in the subendothelial space where they undergo oxidative modifications. Oxidized LDL (oxLDL) alter the fragile balance between survival and death of vascular smooth muscle cells (VSMC) thereby leading to plaque instability and finally to atherothrombotic events. As protein kinase C d (PKCd) is pro-apoptotic in many cell types, we investigated its potential role in the regulation of VSMC apoptosis induced by oxLDL. We found that human VSMC silenced for PKCd exhibited a protection towards oxLDL-induced apoptosis. OxLDL triggered the activation of PKCd as shown by its phosphorylation and nuclear translocation. PKCd activation was dependent on the reactive oxygen species generated by oxLDL. Moreover, we demonstrated that PKCd participates in oxLDL-induced endoplasmic reticulum (ER) stress-dependent apoptotic signaling mainly through the IRE1a/JNK pathway. Finally, the role of PKCd in the development of atherosclerosis was supported by immunohistological analyses showing the colocalization of activated PKCd with ER stress and lipid peroxidation markers in human atherosclerotic lesions. These findings highlight a role for PKCd as a key regulator of oxLDL-induced ER stress-mediated apoptosis in VSMC, which may contribute to atherosclerotic plaque instability and rupture. Atherosclerosis is a slow degenerative process and is the underlying cause of heart attacks, strokes, and peripheral artery diseases in humans. This complex disorder is characterized by the focal accumulation of lipids and the remodeling of the arterial wall, leading to the formation of the atherosclerotic plaque. Modified lipoproteins, specially oxidized low-density lipoproteins (oxLDL), are present within atheroma plaques, and are thought to play a role in atherogenesis. 1 OxLDL exhibit a variety of atherogenic properties, by inducing foam cell formation, inflammatory response, cell proliferation, at low concentration, and apoptosis at higher concentration. 2, 3 The balance between aberrant proliferation and apoptosis is responsible for mediating intense changes in the development of atherosclerosis. Apoptosis of vascular smooth muscle cells (VSMC) increases as atherosclerotic plaques develop and is sufficient to induce features of plaque vulnerability in atherosclerosis. 4 Overall, loss of VSMC is detrimental for plaque stability and increases the risk of thrombotic events.
The apoptotic signaling triggered by oxLDL is mediated through a complex sequence of signaling events that lead to activation of caspase-dependent or caspase-independent apoptotic pathways. We previously reported that treatment of human VSMC with oxLDL induced a sustained rise of cytosolic calcium, leading to the activation of the intrinsic mitochondrial apoptotic pathway. 5, 6 More recently, we showed in human vascular endothelial cells an interaction between the deregulation of cytosolic calcium and the endoplasmic reticulum (ER) stress in triggering the apoptotic response induced by oxLDL. 7 ER plays an essential role in sensing cellular stress (i.e., accumulation of misfolded proteins, potential redox or calcium deregulation) as it rapidly detects changes in cell homeostasis, and responds by eliciting UPR (unfolded protein response) via the activation of ER transmembrane sensors, PERK (double-stranded RNAdependent protein kinase (PKR)-like ER kinase), IRE1a (inositol-requiring 1a) and ATF6 (activating transcription factor 6). The UPR results in a temporary downregulation of protein translation, an upregulation of ER chaperones and folding machinery, and the expression and activation of ER-associated degradation (ERAD). 8 Prolonged ER stress switches towards apoptotic cell death via the activation of downstream signals like CHOP (C/EBP homologous protein), JNK and members of the Bcl-2 family.
9,10 Our previous data 11 and those from Myoishi et al. 12 demonstrated that ER stress markers are present in human advanced atherosclerotic lesions thus raising the question of the possible role of ER stress in the stability/instability of atherosclerotic plaques, since this adaptive response may influence the fate of cells to survive or die.
Protein kinase C d (PKCd), a member of the PKC family of serine-threonine kinases, is known to be a critical pro-apoptotic signal in many cell types. 13 More particularly, PKCd-deficient mice develop exacerbated intimal hyperplasia associated with diminished SMC apoptosis in vein grafts 14 and carotid ligation models, 15 indicating that PKCd is an important regulator of SMC apoptosis after vascular injury. Recently, it has been shown that PKCd plays a crucial role in the propagation of TNFa-induced ER stress-mediated JNK activation and CHOP/GADD53 induction. 16 Hitherto, whether PKCd contributes to oxLDL-induced vascular SMC apoptosis and ER stress is not known.
Here, we investigated the possible involvement of PKCd in the apoptotic signaling pathway triggered by oxLDL and its role in the transmission of the pro-apoptotic signal of the ER stress in human VSMC. We found that oxLDL mediate PKCd activation through reactive oxygen species (ROS) production and that PKCd plays a crucial role in the regulation of oxLDLinduced apoptosis mainly through the IRE1a/JNK pathway of ER stress. Importantly, we provided evidence that activated PKCd is colocalized with ER stress and lipid peroxidation markers in human atherosclerotic lesions.
Results
SiRNA-mediated suppression of PKCd expression reduces oxLDL-induced human vascular smooth muscle apoptosis. We first investigated the involvement of PKCd in the apoptosis of human vascular smooth muscle (hVSMC) cells treated with oxLDL. The expression of PKCd was silenced by small interfering RNA (siRNA) specific to human PKCdAs shown in Figure 1a . The inhibitory effect of siRNA on PKCd expression was obvious 48 h after transfection and was not influenced by treatment with oxLDL. To assess whether the effect of PKCd knockdown relates to hVSMC survival, PKCd knockdown ()()and control cells were treated with oxLDL for 24 h. PKCd knockdown cells displayed a protection towards oxLDL-induced apoptosis as demonstrated by a significant decrease in cell death (Figure 1b) . The involvement of caspase-3 is supported by the protective effect of the multicaspase inhibitor z-VAD-fmk against oxLDL-induced apoposis (Figure 1c) . We also showed the release of cytochrome C from the mitochondria, which is accompanied by an increased expression of the pro-apoptotic protein Bak and a decreased expression of the pro-survival protein Bcl-2 in agreement with the data of Yang et al. 17 (Supplementary Figure S1) . The activation of caspase-3 is prevented in PKCd knockdown cells as shown by the inhibition of its cleavage, compared with control cells (Figure 1d) .
We further demonstrated the involvement of PKCd in the apoptosis induced by oxLDL by the use of mouse embryonic fibroblasts (MEF) invalided for PKCd MEF PKCd À / À ) that showed a strong resistance to oxLDL-induced cell death as explored by cell viability assay, apoptotic characteristics, Bcl-2 expression, cytochrome C release and caspase-3 cleavage compared with MEF PKCd cells (Figures 2a-e) . Moreover, the central role of PKCd in the broad regulation()of apoptosis is supported by the protection of MEF PKCd À / À cells towards the apoptotic inducer antimycin A (Figure 2a) .
The resistance to apoptosis in PKCd À / À cells likely results from the loss of PKCd expression, to prove that apoptosis is directly dependent on PKCd we asked if the re-expression of PKCd is sufficient to restore the apoptotic response induced by oxLDL.
MEF PKCd À / À cells were transduced with adenovirus expressing either GFP (AdGFP) or a PKCd-GFP (AdPKCd-GFP) fusion protein ( Figure 3a) . As shown in Figure 3b , transduction of AdPKCd-GFP completely re-establishes their apoptotic response to oxLDL, whereas PKCd À / À cells transduced with AdGFP remained resistant to oxLDL-induced apoptosis. Our data clearly demonstrate that re-expression of PKCd in PKCd À / À cells reconstitute apoptotic potential. Altogether, our results indicate that PKCd plays a major role in the apoptosis induced by oxLDL.
PKCd is activated in response to oxLDL stimulation in human vascular smooth muscle. The ability of PKCd to activate an apoptotic program is regulated by key events such as phosphorylation on specific tyrosine residues and nuclear accumulation where it may be cleaved by caspase to generate a pro-apoptotic PKCd catalytic fragment (dCF). 13 We analyzed the phosphorylation of PKCd on tyrosine 311 because (i) this critical residue located in the catalytic domain is phosphorylated in response to apoptotic stimulus such as oxidative stress induced by hydrogen peroxide 18, 19 and because (ii) oxLDL treatment generates an oxidative stress through the production of hydrogen peroxide (H 2 O 2 ) and superoxide anion (O 2 À ). 20 To examine the effect of oxLDL on PKCd tyrosine 311 phosphorylation, hVSMC were treated with increasing concentrations of oxLDL (0-200 mg ApoB/ml) for 5 h or with cytotoxic concentration of oxLDL (200 mg ApoB/ml) for 1-8 h. As shown in Figure 4a , the phosphorylation level of tyrosine 311 increases with the concentration of oxLDL and with the length of time treatment being visible at 5 h stimulation. We then followed the nuclear translocation of PKCd by two methods: cell fractionation and fluorescence microscopy. After hVSMC treatment with oxLDL, the nuclear and cytosolic fractions were separated by differential centrifugation. We found that in untreated cells, PKCd was expressed in the cytosol and translocated to the nucleus beyond 12 h of oxLDL stimulation (Figure 4b ). Using immunofluorescence microscopy, we confirmed that PKCd was located mostly in the cytosol in untreated control cells and that oxLDL induced the translocation of PKCd to the nucleus in about 90-95% of the cells as observed following 18 h treatment with oxLDL ( Figure 4c) . Collectively, these data show that oxLDL induce the activation of PKCd to trigger hVSMC apoptosis.
ROS generated by oxLDL contribute to the activation of PKCd. We then questioned the mechanisms involved in oxLDL-induced PKCd activation. We previously showed that oxLDL trigger an intracellular rise in ROS in rabbit smooth muscle cells. 21 Therefore, we investigated whether oxLDL-induced ROS generation is involved in PKCd tyrosine 311 phosphorylation. Incubation of hVSMC with oxLDL but not with nLDL (data not shown) resulted in a rapid increase of intracellular ROS as assessed by the rise of DCF fluorescence ( Figure 5a ). OxLDL-mediated ROS production is prevented by preincubation with the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo [4,5-d] pyrimidine (VAS2870, 10 mM) and with the addition of a cell permeable form of the antioxidant enzyme catalase (PEGcatalase 50 UI/ml). Indeed, addition of PEG-conjugated enzyme produces an increase in plasma membrane fluidity, thus enhancing cell association and uptake. 22 These data suggest that NADPH oxidases play a major role in the generation of ROS by oxLDL and that H 2 O 2 produced through the dismutation of O 2 À might be the mediator of ROS-induced cell signaling. We further analyzed the inhibitory efficiency of VAS2870 and PEG-catalase on the tyrosine 311 phosphorylation of PKCd. As shown in Figure 5b , both antioxidants were able to prevent oxLDLinduced PKCd phosphorylation in hVSMC. These findings demonstrate that oxLDL generate intracellular ROS responsible for PKCd activation. Moreover, the inhibitory effect of VAS2870 suggests that ROS production depends on the activity of NADPH oxidase in hVSMC.
The UPR is induced upon oxLDL stimulation and the activation of the ER stress-dependent IRE1/JNK pathway is dependent on PKCd expression. It has been Immunoblots representative of three independent experiments, were performed on cell lysates using anti-procaspase-3, anti-cleaved caspase-3 antibodies and b-actin was used as a loading control recently shown that PKCd participates in ER stress-induced apoptosis in mouse neuroblastoma cells. 23 To determine whether UPR is induced in hVSMC following oxLDL treatment, we investigated the activation of the three classical ER sensors: PERK, IRE1a and ATF6. Our data showed the phosphorylation of the PERK substrate eIF2a an increase expression of IRE1a 24 and the nuclear translocation of ATF6 upon oxLDL stimulation in hVSMC (Figures 6a and  b) . Because oxLDL trigger a prolonged ER stress activation, which may have a role in apoptotic cell death through IRE1a-TRAF2-JNK pathway and CHOP expression, we checked the activation of these proapoptotic pathways in hVSMC. OxLDL elicited the activation of JNK and the expression of CHOP protein (Figure 6c ), which is in agreement with our previous studies showing the contribution of these two ER stress proapoptotic mediators in oxLDL-induced human endothelial cell apoptosis. 7 We provided further evidence for the role of the ER stress induced by oxLDL in the apoptosis of hVSMC by showing the induction of PUMA (p53 upregulated modulator of apoptosis) and BIM (BCL-2 interacting mediator of cell death), two pro-apoptotic BH3 domain-only proteins regulated by CHOP in response to ER stress (Figure 6d) .
We next explored whether PKCd plays a role in oxLDLinduced ER stress signaling. We observed the phosphorylation of the PERK substrate eIF2a and the nuclear translocation of ATF6 in MEF PKCd þ / þ and PKCd À / À cells following oxLDL treatment (Figures 7a and b) . On the other side, in PKCd þ / þ cells oxLDL induced the expression of IRE1a and CHOP, and JNK activation whereas PKCd À / À cells treated with oxLDL displayed neither increased expression of IRE1a nor JNK activation but showed an increased expression of CHOP (Figures 7a and c) .
We then asked whether PKCd was necessary for the induction of the UPR. MEF PKCd þ / þ and PKCd cells were stimulated by thapsigargin a potent inducer of ER stress. The activation of the UPR and the ER stress proapoptotic mediators was observed in cells expressing or not PKCd Figure S2) , indicating that PKCd does not globally regulate the ER stress. Therefore, our results demonstrated for the first time that PKCd participates in oxLDL-induced ER stress-dependent apoptotic signaling mainly through the IRE1/JNK pathway.
Activated PKCd colocalized with ER stress and oxidative markers in human atherosclerotic lesions. Since oxLDL and oxidized lipids are found in atherosclerotic lesions, we investigated whether PKCd phosphorylated on tyrosine 311 is expressed in human atherosclerotic lesions of carotid endarterectomy. Immunostaining of phosphorylated PKCd was strongly positive in the necrotic core of advanced atherosclerotic lesions compared with normal mammary artery where phosphorylated PKCd was not detected (Figure 8) . Interestingly, the staining of UPR markers with KDEL (Lys-Asp-Glu-Leu) antibody that recognizes both ER chaperones GRP78 and GRP94, was increased in advanced lesions and colocalized with PKCd phosphorylated and the lipid peroxidation marker 4-hydroxynonenal (4-HNE). In normal artery, there was no KDEL or 4-HNE positivity. Furthermore, we confirmed that KDEL-, 4-HNE-and activated PKCd-positive cells were foams cells (SMC and macrophages) of the necrotic core as shown by immunostaining of serial sections with anti-CD68 antibody. These results support our in vitro data and strongly suggest that PKCd and ER stress may be activated by oxidized lipids within the atherosclerotic lesions.
Discussion
OxLDL-induced apoptosis of vascular cells may contribute to the erosion and instability of atherosclerotic plaques, thereby increasing the risk of subsequent thrombotic events. In this study, we identified a novel regulatory pathway in oxLDLinduced apoptosis of VSMC. We report for the first time that PKCd is activated by oxLDL in human VSMC and contributes to oxLDL-induced ER stress-dependent apoptotic signaling through the I IRE1a/JNK pathway.
The function of PKCd depends on the cell type and specific stimulus but currently a large number of studies are consistent with the central role of PKCd in the regulation of cell apoptosis in response to various apoptotic stimuli. 25 We showed that knockdown of PKCd expression significatively reduces the effect of oxLDL-induced apoptosis in primary human VSMC and reintroduction of PKCd into PKCd knockout cells restores their apoptotic capacity, indicating that PKCd is sufficient to specifically control the ability of the cells to undergo apoptosis. In addition, the modulation of the expression of pro-apoptotic and pro-survival members of the Bcl-2 family and, the reduced release of cytochrome C in PKCd knockout cells suggests that PKCd plays a central role in the mitochondria-dependent apoptotic pathway triggered by oxLDL. Altogether our findings corroborate previous results showing that forced higher expression in normal VSMC increased their apoptotic responses to the H 2 O 2 . 15 However, it has been demonstrated that SMC isolated from PKCd knockout mice displayed decreased proliferation compared with wild-type SMC; 26 thus, suggesting that PKCd exhibits contrasting roles in cell death and cell proliferation. In our experimental conditions, we did not observe such modification in cell viability and cell number in human VSMC knockdown for PKCd, therefore, supporting that the proapoptotic function of PKCd depends on the biological context.
PKCd is activated by a large array of stimuli including mechanical stress, pro-inflammatory cytokines and oxidative stress, which are known to be associated with vascular remodeling and atherogenesis. The generation of ROS induced by oxLDL raises the question regarding how PKCd is activated, which may include binding of second messenger diacyglycerol, phosphorylation, membrane translocation and proteolysis. One of the key event involved in the transduction of a death signal to PKCd is the phosphorylation of PKCd on tyrosine residues. In this study, we provided evidence that the rise in intracellular ROS triggered the phosphorylation of the tyrosine 311 residue of PKCd which have been linked to increased kinase activity and apoptosis in cells treated with H 2 O 2 . 18 The inhibitory effect of VAS2870, a well-validated expressing AdPKCd-GFP. Cells treated with oxLDL showed chromatin condensation and appearance of apoptotic bodies, because of the brightness of SYTO-13, GFP fluorescence is not apparent Role of PKCd in oxidized LDL-induced apoptosis P Larroque-Cardoso et al specific inhibitor of NADPH oxidase (NOX), 27 on oxLDLinduced ROS production and PKCd tyrosine 311 phosphorylation raises the question of the enzymatic sources of ROS. Our data are consistent with the work of Stielow who showed that the VAS2870 inhibited 28 oxLDL-induced ROS production in HUVEC. Moreover, the antioxidant enzyme catalase exerts the same inhibitory effect as VAS2870, which also supports a potential role of H 2 O 2 generated by oxLDL treatment on PKCd activation.
The main substrates of PKCd in apoptotic cells are nuclear proteins and it has been shown that PKCd translocates from the cytoplasm to the nucleus in response to specific apoptotic stimuli. 29 Indeed, a nuclear localization sequence (NLS) has been defined in PKCd that is required for its ability to induce apoptosis. 30 As we observed a nuclear localization of PKCd following oxLDL stimulation, we can hypothesize that oxLDL through the production of ROS, may induce post-translational (a) Measurement of intracellular ROS production using the free radical sensor: H 2 DCFDA (6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate). Human VSMC were pretreated with the NADPH inhibitor (VAS-2870, 10 mM) or with PEGcatalase (50 UI/ml) for 1 h, then incubated with oxLDL (200 mg apoB/mL) for 0.5, 1 and 5 h. The variation of intracellular ROS was detected by fluorescence intensity using using the free radical sensor: 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate as described under 'Materials and Methods.' Results were normalized on protein levels and expressed in ratio to untreated control. The data are expressed as mean±S.E.M. of five separate experiments *or #Po0.05; **or ##Po0.01 indicate significance, (# comparison between untreated cells and oxLDL-treated cells, *comparison between oxLDL-treated cells and oxLDL þ VAS2870, between oxLDL-treated cells and oxLDL þ catalase). ns indicates no significance. (b) Analysis of oxLDL-induced PKCd phosphorylation in human VSMC pretreated with NADPH inhibitor (VAS-2870, 10 mM) or with PEG-catalase (50 UI/ml). Western blot experiments were performed on total protein extracts treated with oxLDL (200 mg ApoB/ml) for 8 h, using anti-phosphotyrosine 311 PKCd antibody and total PKCd expression was used as loading control. The graph represents values of phosphotyrosine 311 PKCd band intensity after normalization for total PKCd by densitometry, **Po0.01 indicates significance (comparison between oxLDL and oxLDL þ VAS2870, between oxLDL and oxLDL þ catalase). Blots are representative of three independent experiments Role of PKCd in oxidized LDL-induced apoptosis P Larroque-Cardoso et al modifications in PKCd, which allow its translocation into the nucleus. Although in some systems, apoptotic cell death is associated with caspase-3-dependent cleavage of PKCd, we did not observe any formation of the catalytically active fragment of PKCd in our cellular model following oxLDL treatment. Nevertheless, our results are consistent with other reports showing lack of proteolytic cleavage of PKCd in H 2 O 2 -rendered apoptotic CHO cells 18 or in phorbol ester-induced apoptosis in prostate cancer cells. 31 In agreement with our previous data reporting that oxLDL induced UPR and triggered ER stress-dependent apoptosis in human endothelial cells, 7, 11 the current study demonstrated the activation of UPR sensors/ER stress in human VSMC exposed to oxLDL. The cellular response to a prolonged and excessive ER stress includes the activation of signaling pathways, which lead to apoptosis as supported by the increased expression of the proapoptotic factor CHOP/ GADD53 and its targets BIM and PUMA, and the activation of the IRE1/JNK pathway in oxLDL-stimulated VSMC. To go further on the mechanisms mediating the apoptotic effect of PKCd, we examined the potential link between ER stress and PKCd Interestingly, we found that PKCd participates in oxLDL-induced ER stress-dependent apoptotic signaling mainly through the IRE1a/JNK pathway. Indeed, we observed that in PKCd À / À cells, oxLDL induced PERK activation, ATF6 nuclear translocation and CHOP induction but not IRE1a/JNK activation, which is consistent with previous report showing that inhibition of PKCd reduces ER stress-induced JNK activation in Neuro2a cells. 23 However, the regulatory role of PKCd on ER stress is dependent on the signaling pathway triggered by the stimuli as thapsigargin induced UPR in cells expressing or not PKCd, thus, indicating that PKCd does not globally regulate ER stress.
The physiological importance of PKCd in the development of atherosclerotic lesions is evidenced by our immunohistological analyses as we observed the expression of tyrosine 311 phosphorylated PKCd in advanced human atherosclerotic lesions. Interestingly, the expression of phosphorylated PKCd colocalized in atherosclerotic areas containing 4-HNE adducts and ER stress marker such as KDEL-positive cells, thus, suggesting that oxLDL through lipid peroxidation derivatives may locally contribute to trigger PKCd activation and ER stress. These findings indicate that a similar activation mechanism of PKCd such as we described in human VSMC exists in the atherosclerotic lesion. Moreover, our results corroborate the work of Yamanouchi et al. 15 that showed a robust expression of PKCd in apoptotic cells of human restenotic lesions.
Finally, our study identify for the first time PKCd as a major regulator of oxLDL-induced apoptosis in VSMC, we also provide evidence that ROS generated by oxLDL are responsible for PKCd activation. Furthermore, the involvement of PKCd in the transmission of ER stress-dependent apoptotic signaling mainly through the IRE1a/JNK pathway, points out that PKCd is involved in the fine tuning of apoptosis and raises the question of its role in the stability of atherosclerotic plaque.
Materials and Methods
Reagents. Cell culture reagents were from Invitrogen Life Technologies (Saint Aubin, France). SYTO-13, propidium iodide and 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H 2 DCFDA) were from Molecular Probes (Invitrogen). VAS2870 was from Enzo Life Sciences (Villeurbanne, France), PEG-Catalase and 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), antimycin A from Sigma-Aldrich (Lyon, France). z-VAD-FMK was from R&D Systems Europe (Lille, France). Thapsigargin is from Calbiochem (Millipore, Saint-Quentin-enYvelines, France). Following antibodies were used: anti-phospho-PKCd, anti-IRE1a, anti-phospho-eIF2a, anti-phospho-JNK, anti-CHOP, anti-caspase-3, Cell culture. Human primary VSMC were obtained from human mesenteric arteries at postmortem examinations. All experiments were conformed to the declaration of Helsinki in compliance with French legislation and written informed consent was obtained from patients for the use of surgery residual tissue for research. Briefly, the arteries were cut longitudinally and small pieces of the media were carefully stripped from the vessel wall and cultured. Within 1-2 weeks, SMC migrated from the explants; they were capable of being passaged 3 weeks after the first appearance of cells. They were identified as VSMC by their characteristic hill-and-valley growth pattern and immunohistochemistry for VSMC-specific aactin. The primary cultured human VSMC were used to generate an immortalized cell line by using SV40T antigen, SV40T-expressing human VSMC retain expression of contractile phenotype markers including smooth muscle a-actin and smMHC to passage 10 and higher as we previously described. 32 For all experiments, passage 7-17 SV40T-expressing human VSMC cultures were used. The cultures were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum at 37 1C in a humidified, 5% CO 2 /95% air atmosphere. MEF from PKCd À / À mice and wild-type MEF were a generous gift from Pr. Mary E Reyland (University of Colorado Denver, USA). 33 MEF PKCd
and WT were maintained in DMEM supplemented with 10% fetal calf serum at 37 1C in a humidified, 5% CO 2 /95% air atmosphere.
Adenovirus expression in MEF PKCd
À / À . The generation and the use of Ad PKCd-GFP and AdGFP have been described previously. 33 MEF PKCd
were infected with Ad PKCd-GFP or AdGFP at a multiplicity (focus forming units/cell) of 100. Cells were infected in serum-free DMEM over night after which the virus containing medium was removed and replaced with normal medium. Infection was allowed to proceed for 24 h before stimulation with oxidized LDL.
LDL isolation and mild oxidation. LDL from human pooled sera were prepared by ultracentrifugation, dialyzed against PBS containing 100 mM EDTA. LDL were mildly oxidized by UV-C þ copper/EDTA (5 mM) (oxLDL) as previously reported. 34 OxLDL contained 4.2-7.4 nmol of TBARS (thiobarbituric acid À reactive substances)/mg apoB. Relative electrophoretic mobility (REM) and 2,4,6-trinitrobenzenesulfonic acid (TNBS) reactive amino groups were 1.2-1.3 times and 85-92% of native LDL, respectively.
Nuclear and cytosolic fractionation. Cells were washed once with PBS and lysed in a buffer containing 10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM EDTA, 0.5 mM EDGA, proteases inhibitors, 0.1% Nonidet P-40 pH 7.9 for 10 min on ice and homogenates were centrifuged at 800Âg at 4 1C for 10 min. The supernatant that contains the cytoplasmic fraction was transferred and saved for western blotting analysis. The nuclear pellet was resuspended in extraction buffer containing 20 mM HEPES, 1.5 mM MgCl 2 , 0.2 mM EDTA, 100 mM NaCl, 26% glycerol (v/v), pH 7.9 for 30 min on ice with vortexing at 10-min internals. Homogenates were centrifuged for 30 min at 14 000Âg at 4 1C and the supernatant that contains the nuclear fraction was transferred and saved for western blotting analysis.
Western blot analysis. Cells were lysed in solubilizing buffer (10 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 5 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml aprotinin) for 30 min on ice. In all, 40 mg of protein cell extracts were resolved by SDS-polyacrylamide gel electrophoresis, transferred onto PVDF membranes (Millipore). Then membranes were probed with the indicated primary antibodies and revealed with the secondary antibodies coupled to horseradish peroxidase using the ECL chemoluminescence kit. Membranes were then stripped and reprobed with anti-b-actin antibody to control equal loading of proteins.
Evaluation of cytotoxicity, necrosis and apoptosis. For cytotoxicity experiments, cells were serum starved for 24 h and stimulated for the indicated times at 37 1C. Cytotoxicity was evaluated using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test, as previously used. 7 This method is À / À and MEF PKCd þ / þ treated with oxLDL (200 mg ApoB/ml). Western blot experiments were performed on total protein extracts, cell lysates were assessed for phospho-JNK and CHOP expression. b-Actin was used as protein loading control. Blots are representative of three independent experiments based on MTT reduction by the respiratory chain and other electron transport systems leading to form non-water-soluble violet formazan crystals that can be determined spectrophotometrically (OD measured at 570 nm) and serves as an estimate for the metabolic activity of living cells. Apoptotic and necrotic cells were counted after fluorescent staining by two fluorescent dyes, the permeant DNA intercalating green fluorescent probe SYTO-13 (0.6 mM) and the non-permeant DNA intercalating red fluorescent probe propidium iodide (15 mM) using an inverted fluorescence microscope (Fluovert FU, Leitz, Grand rapids, MI, USA) as previously described. 7 Normal nuclei exhibit a loose green-colored chromatin. Nuclei of primary necrotic cells exhibit loose red-colored chromatin. Apoptotic nuclei exhibited condensed yellow/green-colored chromatin associated with nucleus fragmentation, whereas post-apoptotic necrotic cells exhibited the same morphological features, but were red-colored.
SiRNA transfection. The selected siRNA specific to human PKCd were ON-TARGET plus SMART pool siRNA human PKCd (Dharmacon, Waltham, MA, USA). SiRNAs were transfected using the Hiperfect reagent (Quiagen, Courtaboeuf, France) according to the manufacturer's recommendations.
Immunofluorescence. Human VSMC grown on cover glass slides were washed with PBS and fixed in PBS/4% paraformaldehyde for 10 min. After blocking with PBS containing 3% BSA for 30 min, cells were incubated with the indicated antibodies for 1 h and revealed with Alexa Fluor 488-conjugated secondary antibody for 1 h. The slides were visualized using a Zeiss LSM 510 fluorescence confocal microscope (Le Pecq, France).
Quantification of intracellular ROS. The generation of intracellular ROS was estimated using the 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H 2 DCFDA) ROS-sensitive fluorescent probe (5 mM). Stimulated cells were incubated with the probe 30 min before determination as described. 21 Immunohistochemistry. Human advanced carotid plaques (patients 70-75 years old) were obtained after endarterectomy (Cardiovascular Surgery Department, CHU Toulouse, France), internal mammary arteries were obtained from patients undergoing coronary artery bypass grafting. Tissues were fixed in formalin and paraffin embedded. Serial 3 mm thin sections were incubated with the anti-phosphotyrosine 311 PKCd anti-KDEL, anti-4-HNE-adduct, anti-CD68 and anti-a-actin antibodies, then with appropriate biotin-labeled antibodies, and revealed by using avidin-biotin horseradish peroxidase visualization system (Vectastain, ABC kit Elite, Vector Laboratories, Burlingame, CA, USA). All experiments were conformed to the declaration of Helsinki in compliance with French legislation and written informed consent was obtained from patients for the use of surgery residual tissue for research.
Statistical analysis. Data are given as mean ± S.E.M. Statistical comparison of the data was performed using the t-test for comparison between two groups and is explained in the figure legends (Sigma stat software, San Jose, CA, USA). Values of Po0.05 were considered statistically significant.
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